Trkulja V. There is no reasonable evidence to support efficacy of fluvoxamine in prevention of disease deterioration in COVID-19 outpatients: a comment on two recent meta-analyses advocating its use. J Infect 2022 Nov 24:S0163-4453(22)00677-6. doi: 10.1016/j.jinf.2022.
PMID: 36436621